They managed it! Who would have dared put their money on the FCI European Section's
2012 Show in Bucharest being such a resounding success? Victim of a smear campaign
on the social networks (what power, what strength, often positive but at times also
very harmful), the Asociatia Chinologica Romana (AchR) was able to keep a cool head,
rising to the challenge and attracting more than 6,000 dogs to the Romanian capital.
The AChR was able to leverage the smear campaign against it to promote the show,
and the least we can say is that it was very successful in doing so. Congratulations
to the whole Romanian team, brilliantly led by Mr C. Stefanescu and Mr P. Muntean.
Unfortunately, three of the canine world’s top personalities have recently left
us and the FCI would like to pay tribute to them here...
Read more
Yves De Clercq
FCI Executive Director
Dogs and human beings help each other in the search for the molecular bases of genetic
diseases they have in common
The study of genetic diseases in different breeds of dogs is very interesting, not
just for veterinary medicine but also for human medicine.
The "Canine Genetics" team under the leadership of Dr Catherine André at the Rennes
Institute of Genetics and Development has for more than ten years been conducting
a number of research projects aimed at determining the molecular bases for genetic
diseases in dogs. This research is targeting diseases whose clinical indications,
genetic causes and therapeutic responses are shared by human beings and dogs. It
thus provides a twofold benefit, for both dogs and human beings, improving diagnosis
and screening through the introduction of genetic tests and the opening up opportunities
of better therapeutic care.
More than 500 genetic diseases are listed for dogs. In many cases they are specific
to certain breeds and their frequency can reach up to 20% within a given breed,
posing real problems for the health and even the longevity of certain breeds.
The Rennes researchers have collected samples from infected dogs and healthy dogs
of the same breed (the control cases) and their families as a way of researching
the genetic causes of different diseases in different breeds. Since 2000, Cani-DNA
- a bio-bank full of samples from dogs - has been developed at the CNRS in Rennes,
following the establishment of a network of vets and breeders with the help of AFVAC
and the French Kennel Club, the Société Centrale Canine. This network is basically
made up of practicing vets, the four French schools of veterinary medicine, the
company Antagène and various veterinary labs specialised in analyses and histopathology.
The genetic analyses carried out at the CNRS in Rennes start with taking blood samples
from the infected dogs and their families. The DNA of each dog is then extracted
and hundreds of thousands of genetic markers analysed for each canine DNA. This
work ends with the production of a precise genetic map for each dog. The aim of
the subsequent genetic and statistical analyses is to compare the genetic maps of
infected dogs with those of healthy dogs, pinpointing the region of the genome possibly
at the origin of the disease.
Here are a few examples of research in progress at the Rennes laboratory.
- The histiocytic sarcoma, a very aggressive tumour that spreads quickly to several
organs, is particularly common in the Bernese Mountain Dog, the Flat Coated Retriever
and the Rottweiler, while the disease is rare in other breeds. This type of cancer
also exists in human beings, where it is very serious. Due to the fact that there
are so few cases among human beings, there is hardly any genetic research done.
No effective therapy currently exists, and evidently research into the canine form
of the disease will benefit both dogs and human beings.
- The acral mutilation syndrome is found in breeds of hunting dogs, including the
French Spaniel. This sensory neuropathy, probably due to innervation defects in
a dog’s limbs, leads to limbs being mutilated. Mutilation can be very severe, and
in the most serious cases, leads to the dog having to be put down. Several forms
of sensory neuropathy exist in human beings, where they are classified as HSAN (Hereditary
Sensory and Autonomous Neuropathy) disorders. Though genes have already been identified,
they do not explain all forms; thus, finding new genes in dogs should help boost
the number of genes involved in human beings.
- Retinopathy is characterised by a progressive sight disorder, usually ending in
complete blindness. More than 100 breeds suffer from progressive retinal atrophy,
including the Border Collie. Again, research into the genetic cause in the Border
Collie is ongoing; studies already completed show a transmission linked to chromosome
X. In humans, there are also many forms of this disease, which is called retinitis
pigmentosa. Though its forms are related to chromosome X, its genetic causes are
not yet known. To date, of the dozen known genes in the two species, the majority
are the same.
- Hip dysplasia in large dogs is proving to be a major problem. A partially multigenetic
component is thought to be the cause.
Finally, this type of study has recently allowed us to identify the defective gene
responsible for ichthyosis in the Golden Retriever. This gene, also seen to be the
cause of congenital ichthyosis in human beings, has allowed the discovery of a new
function in the skin barrier. A genetic test has been developed for diagnosing and
screening dogs, and is expected to allow better breeding management and a progressive
decrease in the incidence of the disease in this breed.
Winding up, any dog lover, whether vet, breeder or simply a dog owner, may participate
in these genetic studies, either by providing input to the Cani-DNA bio-bank (dogs
of any breed and any age, healthy or sick), or for specific research projects. All
you need to do is to send in a simple blood sample (3 ml in an EDTA tube), accompanied
by a copy of the dog's pedigree and a filled-in clinical questionnaire provided
by the CNRS.
Catherine André and Anne-Sophie Guillory
For more information:
http://dogs.genouest.org
Contact : Catherine André
Tél. : 02 23 23 45 09
Email :